The stock price of Edwards Lifesciences Corp (NYSE: EW) has dropped by -0.39 compared to previous close of 92.70. Despite this, the company has seen a fall of -2.03% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-25 that Here is how Edwards Lifesciences (EW) and Avinger (AVGR) have performed compared to their sector so far this year.
Is It Worth Investing in Edwards Lifesciences Corp (NYSE: EW) Right Now?
The price-to-earnings ratio for Edwards Lifesciences Corp (NYSE: EW) is above average at 40.12x, Company’s 36-month beta value is 1.08.Analysts have differing opinions on the stock, with 9 analysts rating it as a “buy,” 7 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for EW is 591.80M, and currently, short sellers hold a 1.77% ratio of that floaft. The average trading volume of EW on April 09, 2024 was 4.07M shares.
EW’s Market Performance
EW’s stock has seen a -2.03% decrease for the week, with a -1.57% drop in the past month and a 26.75% gain in the past quarter. The volatility ratio for the week is 2.39%, and the volatility levels for the past 30 days are at 2.11% for Edwards Lifesciences Corp The simple moving average for the last 20 days is -0.92% for EW’s stock, with a simple moving average of 17.14% for the last 200 days.
Analysts’ Opinion of EW
Wells Fargo, on the other hand, stated in their research note that they expect to see EW reach a price target of $94. The rating they have provided for EW stocks is “Overweight” according to the report published on February 02nd, 2024.
Evercore ISI gave a rating of “In-line” to EW, setting the target price at $77 in the report published on January 04th of the current year.
EW Trading at 4.96% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.93% of loss for the given period.
Volatility was left at 2.11%, however, over the last 30 days, the volatility rate increased by 2.39%, as shares surge +0.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.55% upper at present.
During the last 5 trading sessions, EW fell by -2.03%, which changed the moving average for the period of 200-days by +1.37% in comparison to the 20-day moving average, which settled at $93.21. In addition, Edwards Lifesciences Corp saw 21.10% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EW starting from Lemercier Jean-Luc M, who sale 14,400 shares at the price of $92.32 back on Apr 08 ’24. After this action, Lemercier Jean-Luc M now owns 173,849 shares of Edwards Lifesciences Corp, valued at $1,329,472 using the latest closing price.
BOBO DONALD E JR, the CVP,Strategy/Corp Development of Edwards Lifesciences Corp, sale 12,500 shares at $92.33 during a trade that took place back on Apr 08 ’24, which means that BOBO DONALD E JR is holding 39,768 shares at $1,154,142 based on the most recent closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- 0.26 for the present operating margin
- 0.77 for the gross margin
The net margin for Edwards Lifesciences Corp stands at 0.23. The total capital return value is set at 0.19. Equity return is now at value 22.52, with 15.89 for asset returns.
Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at 1.29. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -150.4.
Currently, EBITDA for the company is 1.95 billion with net debt to EBITDA at -0.24. When we switch over and look at the enterprise to sales, we see a ratio of 9.17. The receivables turnover for the company is 7.18for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.38.
Conclusion
In a nutshell, Edwards Lifesciences Corp (EW) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
